近期,因肝损伤相关死亡病例,美国安进公司的罕见病治疗药物阿伐可泮胶囊(中文商品名:特福尼,英文商品名:Tavneos)被美国监管部门提议撤销上市批准,而该药此前也在中国市场获批。 5月22日,安进中国向澎湃新闻记者表示,在中国,阿伐可泮胶囊已于2024年11月获得中国国家药品监督管理局(NMPA)批准,但尚未商业化上市,截至目前中国尚无患者接受特福尼治疗。 阿伐可泮胶囊是一款口服选择性补体...
Source Link近期,因肝损伤相关死亡病例,美国安进公司的罕见病治疗药物阿伐可泮胶囊(中文商品名:特福尼,英文商品名:Tavneos)被美国监管部门提议撤销上市批准,而该药此前也在中国市场获批。 5月22日,安进中国向澎湃新闻记者表示,在中国,阿伐可泮胶囊已于2024年11月获得中国国家药品监督管理局(NMPA)批准,但尚未商业化上市,截至目前中国尚无患者接受特福尼治疗。 阿伐可泮胶囊是一款口服选择性补体...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.